Aß42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

R Radde, T Bolmont, SA Käser, J Coomaraswamy, D Lindau, L Stoltze, ME Calhoun, F Jäggi, H Wolburg, S Gengler, C Haass, B Ghetti, C Czech, Christian Holscher, PM Mathews, M Jucker

    Research output: Contribution to journalArticle

    471 Citations (Scopus)

    Abstract

    Radde R, T Bolmont, S A Käser, J Coomaraswamy, D Lindau, L Stoltze, ME Calhoun, F Jäggi, H Wolburg, S Gengler, C Haass, B Ghetti, C Czech, C Hölscher, PM Mathews, M Jucker (2006). Aß42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
    Original languageEnglish
    Pages (from-to)940-946
    JournalEMBO Reports
    Volume7
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'Aß42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology'. Together they form a unique fingerprint.

  • Cite this

    Radde, R., Bolmont, T., Käser, SA., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, ME., Jäggi, F., Wolburg, H., Gengler, S., Haass, C., Ghetti, B., Czech, C., Holscher, C., Mathews, PM., & Jucker, M. (2006). Aß42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Reports, 7, 940-946.